<DOC>
	<DOC>NCT02484131</DOC>
	<brief_summary>The purpose of this study is to test the feasibility of the study protocol. The study protocol was designed to evaluate questions - "Do educational materials improve dual x-ray absorptiometry (DXA) screening rates for women diagnosed with breast cancer" and "Does educational materials delivered by the participant's selected choice change DXA screening rates compared to the conventional mail method?".</brief_summary>
	<brief_title>Bone Health Management for Women Diagnosed With Breast Cancer</brief_title>
	<detailed_description>"Bone health management" for osteoporosis is important for women diagnosed with breast cancer. Osteoporosis can lead to bones breaking easily. Broken bones may make living independently challenging. Effective bone health management can reduce the risk of broken bones. This study will examine whether providing "osteoporosis information" to women diagnosed with breast cancer will promote their bone health management. With the current advance in technology, people are more interested in receiving information by email or smartphone text messaging. This study will also examine whether delivering osteoporosis information in different ways will change bone health management.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Women Is 6575 year old on July 1st, 2015 Lives in British Columbia (BC), Canada Reads and understands the information provided in English Was diagnosed with breast cancer prior to July 1st, 2012 Is not receiving surgery, radiation or chemotherapy for any cancers Has not had breast cancer spread beyond her breast(s) and nearby lymph nodes Has not had screening tests after July 1st, 2012 Is not taking medications prescribed by doctors for osteoporosis Exclusion criteria: Is medically unfit for preventive care (death, cognitive impairment, nursing home admission, severe mental illness, etc), which will be determined by their family doctors Have terminated patientdoctor relationship with her family doctor who is indicated in our record</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>DXA Screening</keyword>
	<keyword>Women</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Survivors</keyword>
	<keyword>Educational materials</keyword>
	<keyword>Personal choices on delivery methods</keyword>
</DOC>